Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedApr 03, 2026
DataAggregated Company Financials
Companies43
- 7D14.7%
- 3M3.8%
- 1Y46.5%
- YTDn/a
The Pharma industry is up 6.2% in the last week, with Hansoh Pharmaceutical Group up 19%. In the same time, Xuanzhu Biopharmaceutical was down 17%. This means that the industry has gained 35% over the past year. Looking forward, earnings are forecast to grow by 17% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Apr 2026 | HK$809.1b | HK$512.1b | HK$29.5b | 15.4x | 27.4x | 1.6x |
| Sun, 01 Mar 2026 | HK$798.4b | HK$501.2b | HK$30.7b | 13.2x | 26x | 1.6x |
| Tue, 27 Jan 2026 | HK$828.7b | HK$493.0b | HK$30.2b | 13.3x | 27.4x | 1.7x |
| Thu, 25 Dec 2025 | HK$798.7b | HK$487.7b | HK$29.9b | 13.3x | 26.7x | 1.6x |
| Sat, 22 Nov 2025 | HK$788.3b | HK$481.9b | HK$29.9b | 13.2x | 26.3x | 1.6x |
| Mon, 20 Oct 2025 | HK$791.2b | HK$479.6b | HK$30.1b | 13.3x | 26.3x | 1.6x |
| Wed, 17 Sep 2025 | HK$817.1b | HK$480.0b | HK$30.6b | 14.2x | 26.7x | 1.7x |
| Fri, 15 Aug 2025 | HK$788.8b | HK$475.4b | HK$29.0b | 11.7x | 27.2x | 1.7x |
| Sun, 13 Jul 2025 | HK$661.3b | HK$476.0b | HK$29.1b | 11.4x | 22.7x | 1.4x |
| Tue, 10 Jun 2025 | HK$638.6b | HK$476.6b | HK$28.8b | 11.7x | 22.2x | 1.3x |
| Thu, 08 May 2025 | HK$503.7b | HK$470.9b | HK$28.8b | 10.4x | 17.5x | 1.1x |
| Sat, 05 Apr 2025 | HK$502.7b | HK$468.2b | HK$28.7b | 10.1x | 17.5x | 1.1x |
| Mon, 03 Mar 2025 | HK$436.2b | HK$461.6b | HK$31.8b | 8.4x | 13.7x | 0.9x |
| Wed, 29 Jan 2025 | HK$410.5b | HK$464.5b | HK$32.0b | 8.5x | 12.8x | 0.9x |
| Fri, 27 Dec 2024 | HK$437.9b | HK$460.2b | HK$31.7b | 8.5x | 13.8x | 1x |
| Sun, 24 Nov 2024 | HK$433.1b | HK$462.9b | HK$31.5b | 8x | 13.8x | 0.9x |
| Tue, 22 Oct 2024 | HK$488.2b | HK$471.5b | HK$32.8b | 7.9x | 14.9x | 1x |
| Thu, 19 Sep 2024 | HK$434.9b | HK$473.5b | HK$32.9b | 7.4x | 13.2x | 0.9x |
| Sat, 17 Aug 2024 | HK$455.1b | HK$464.1b | HK$32.2b | 8.3x | 14.1x | 1x |
| Mon, 15 Jul 2024 | HK$432.6b | HK$458.8b | HK$32.6b | 7.4x | 13.3x | 0.9x |
| Wed, 12 Jun 2024 | HK$474.5b | HK$463.2b | HK$33.9b | 8.4x | 14x | 1x |
| Fri, 10 May 2024 | HK$483.2b | HK$464.2b | HK$33.8b | 8.5x | 14.3x | 1x |
| Sun, 07 Apr 2024 | HK$440.9b | HK$465.1b | HK$36.5b | 7.2x | 12.1x | 0.9x |
| Tue, 05 Mar 2024 | HK$453.4b | HK$470.6b | HK$33.5b | 8x | 13.5x | 1x |
| Thu, 01 Feb 2024 | HK$400.7b | HK$473.7b | HK$34.0b | 6.8x | 11.8x | 0.8x |
| Sat, 30 Dec 2023 | HK$494.5b | HK$473.7b | HK$34.0b | 7.8x | 14.6x | 1x |
| Mon, 27 Nov 2023 | HK$513.1b | HK$472.5b | HK$32.3b | 7.3x | 15.9x | 1.1x |
| Wed, 25 Oct 2023 | HK$435.0b | HK$469.1b | HK$31.5b | 6.6x | 13.8x | 0.9x |
| Fri, 22 Sep 2023 | HK$418.1b | HK$469.2b | HK$31.5b | 6.7x | 13.3x | 0.9x |
| Sun, 20 Aug 2023 | HK$423.3b | HK$446.0b | HK$28.2b | 9.3x | 15x | 0.9x |
| Tue, 18 Jul 2023 | HK$481.1b | HK$447.0b | HK$27.9b | 9.4x | 17.2x | 1.1x |
| Thu, 15 Jun 2023 | HK$503.2b | HK$447.4b | HK$27.8b | 9.6x | 18.1x | 1.1x |
| Sat, 13 May 2023 | HK$539.5b | HK$452.4b | HK$28.3b | 9x | 19x | 1.2x |
| Mon, 10 Apr 2023 | HK$544.7b | HK$454.0b | HK$28.9b | 9.4x | 18.9x | 1.2x |
Price to Earnings Ratio
18.9x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 26.0x which is higher than its 3-year average PE of 17.9x.
- The 3-year average PS ratio of 1.2x is lower than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 4.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Hong Kong Pharma compare with similar industries?
| HK Market | 1.46% | |
| Healthcare | 11.88% | |
| Pharma | 14.75% | |
| Pharma | 14.75% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$39.36 | 26.4% +HK$49.8b | 66.1% | PE37.7x | |
| 1093 CSPC Pharmaceutical Group | HK$9.71 | 19.0% +HK$17.7b | 75.6% | PE25.2x | |
| 1177 Sino Biopharmaceutical | HK$6.33 | 8.8% +HK$9.0b | 62.7% | PE42.5x | |
| 2096 Simcere Pharmaceutical Group | HK$13.62 | 21.8% +HK$6.3b | 57.3% | PE23x | |
| 3320 China Resources Pharmaceutical Group | HK$6.27 | 17.6% +HK$5.9b | 20.3% | PE8.6x |